Literature DB >> 30602169

Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference.

Giancarlo Logroscino1,2, Marco Piccininni3,4.   

Abstract

Amyotrophic lateral sclerosis (ALS) epidemiology has rapidly developed in the last 30 years alongside the evolving changes in concepts in the field of clinical ALS and also due to the recent proposals of new classification system for motor neuron diseases. Many of these changes in the clinical scenario have been determined through the results of ALS population-based studies conducted in the last 20 years primarily in Europe. All the evidences converge to show that ALS risk is different across continents and ethnicities. In a European registry consortium named EURALS, ALS incident cases were drawn from a source population comprising almost 24 million people across Europe (ALS cases: 1028) and the estimated incidence was 2.2 per 100,000 person-years (py) for the general population. In contrast, other population-based studies have measured the lowest incidence in East Asia to be 0.89 per 100,000 py and in South Asia to be 0.79 per 100,000 py. A large part of Africa, Latin America and Asia does not have any population-based studies. The origin of geographic difference in ALS incidence is a matter of debate. Probably, this is partly due to genes (C9ORF72) and partly due to environmental risk factors. The rapid disappearance of ALS Foci in Guam, Kii, and West Guinea underline the importance of changes in lifestyle and environmental factors. The Global Burden of Disease, a project aiming to describe the burden of all diseases and injuries across all the countries of the world with a standardized protocol, has collected heterogeneous sources of data to estimate the burden of motor neuron diseases. The demographic changes related to increased expectation of life and the growth of the world population indicate that the load of motor neuron disease is rapidly moving toward 400 thousand prevalent cases. The burden is expected to shift toward Asia and Africa in the next decades for the rapid increase of expectation of life of countries with high demographic impact.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Ancestry; C9ORF72; Cohort; Ethnicity; Geographic gradient; Global Burden of Disease; Incidence; Population-based study; Registries

Mesh:

Year:  2019        PMID: 30602169     DOI: 10.1159/000493386

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  26 in total

1.  Approaches for Prevention and Treatment of Neurodegenerative Diseases: ALS and Alzheimer's.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2019-11-08       Impact factor: 4.345

2.  The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016-2018: The Ohio Population-Based ALS Registry.

Authors:  Angeline S Andrew; Erik P Pioro; Meifang Li; Xun Shi; Jiang Gui; Elijah W Stommel; Tanya H Butt; Daniel Peipert; Patricia Henegan; Maeve Tischbein; Pamela Cazzolli; John Novak; Adam Quick; K Doug Pugar; Komal Sawlani; Bashar Katirji; Todd A Hayes; D Kevin Horton; Paul Mehta; Walter G Bradley
Journal:  Neuroepidemiology       Date:  2021-04-26       Impact factor: 3.282

3.  Spatio-temporal clustering of amyotrophic lateral sclerosis in France: A population-based study.

Authors:  Farid Boumédiene; Benoît Marin; Jaime Luna; Vincent Bonneterre; William Camu; Emmeline Lagrange; Gérard Besson; Florence Esselin; Elisa De La Cruz; Géraldine Lautrette; Pierre Marie Preux; Philippe Couratier
Journal:  Eur J Epidemiol       Date:  2022-09-13       Impact factor: 12.434

4.  Extending Brain-Computer Interface Access with a Multilingual Language Model in the P300 Speller.

Authors:  P Loizidou; E Rios; A Marttini; O Keluo-Udeke; J Soetedjo; J Belay; K Perifanos; N Pouratian; W Speier
Journal:  Brain Comput Interfaces (Abingdon)       Date:  2021-12-20

5.  Causal Inference of Genetic Variants and Genes in Amyotrophic Lateral Sclerosis.

Authors:  Siyu Pan; Xinxuan Liu; Tianzi Liu; Zhongming Zhao; Yulin Dai; Yin-Ying Wang; Peilin Jia; Fan Liu
Journal:  Front Genet       Date:  2022-06-22       Impact factor: 4.772

6.  Psychological Support for Family Caregivers of Patients With Amyotrophic Lateral Sclerosis at the Time of the Coronavirus Disease 2019 Pandemic: A Pilot Study Using a Telemedicine Approach.

Authors:  Minoo Sharbafshaaer; Daniela Buonanno; Carla Passaniti; Manuela De Stefano; Sabrina Esposito; Fabrizio Canale; Giulia D'Alvano; Marcello Silvestro; Antonio Russo; Gioacchino Tedeschi; Mattia Siciliano; Francesca Trojsi
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

Review 7.  New Roles for Canonical Transcription Factors in Repeat Expansion Diseases.

Authors:  Lindsey D Goodman; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-12-11       Impact factor: 11.639

Review 8.  Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.

Authors:  Ivana Štětkářová; Edvard Ehler
Journal:  Diagnostics (Basel)       Date:  2021-02-03

Review 9.  Repeat-associated non-AUG (RAN) translation mechanisms are running into focus for GGGGCC-repeat associated ALS/FTD.

Authors:  Lindsey D Goodman; Nancy M Bonini
Journal:  Prog Neurobiol       Date:  2019-09-21       Impact factor: 10.885

Review 10.  FRONTotemporal dementia Incidence European Research Study-FRONTIERS: Rationale and design.

Authors:  Barbara Borroni; Caroline Graff; Orla Hardiman; Albert C Ludolph; Fermin Moreno; Markus Otto; Marco Piccininni; Anne M Remes; James B Rowe; Harro Seelaar; Elka Stefanova; Latchezar Traykov; Giancarlo Logroscino
Journal:  Alzheimers Dement       Date:  2021-08-02       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.